Health-related quality of life and productivity costs in breast cancer patients treated with tamoxifen in the Netherlands
The aim of this study was to describe health-related quality of life (HRQoL) and productivity in Dutch breast cancer patients treated with tamoxifen in an adjuvant setting. Patients who started treatment with a standard dose of tamoxifen and who gave written informed consent, were eligible for participation in this trial. A total of 145 patients were asked to complete a survey at 3 months (T1) and 6 months (T2) after initiation of tamoxifen. HRQoL was measured by the EQ-5D-5L and the FACT-B questionnaire, and productivity by using the iMTA Productivity Costs Questionnaire. At 3 months 137 (95%... Mehr ...
Verfasser: |
Kleijburg, Anne
Braal, C. Louwrens
Westenberg, Justin D.
Jager, Agnes
Koolen, Stijn L.W.
Mathijssen, Ron H.J.
Uyl-de Groot, Carin A.
Wetzelaer, Pim
Penton, Hannah |
Dokumenttyp: |
Artikel |
Erscheinungsdatum: |
2023 |
Reihe/Periodikum: |
Kleijburg , A , Braal , C L , Westenberg , J D , Jager , A , Koolen , S L W , Mathijssen , R H J , Uyl-de Groot , C A , Wetzelaer , P & Penton , H 2023 , ' Health-related quality of life and productivity costs in breast cancer patients treated with tamoxifen in the Netherlands ' , Biomedicine and Pharmacotherapy , vol. 158 , 114158 . https://doi.org/10.1016/j.biopha.2022.114158 |
Schlagwörter: |
/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
/ name=SDG 3 - Good Health and Well-being |
Sprache: |
Englisch |
Permalink: |
https://search.fid-benelux.de/Record/base-27616818 |
Datenquelle: |
BASE;
Originalkatalog |
Powered By: |
BASE |
Link(s) :
|
https://pure.eur.nl/en/publications/e1015786-9319-4e03-9571-b92f554b4fb9 |